Trial intelligence / Profile preview

TRAMORNOT

2025-523327-21-00Phase 4Authorised

Sponsor
CHU Amiens-Picardie
Start
Dec 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of tramadol and morphine in postoperative pain (2 arms), sponsored by CHU Amiens-Picardie. Primary endpoint: QoR-15 score at 24 hours after surgery. Planned start Dec 2025; status: authorised.

02

Drugs

tramadolmorphine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on 2025-523327-21-00.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2025-523327-21-00.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call